Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer - Scorecard - MDSpire

Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer

  • By

  • Hongxia Wang

  • Yijie Li

  • Zhifen Yang

  • Jinxiu Wang

  • Kaiyun Qin

  • Yu Yu

  • Na Wang

  • Jingde Jia

  • Wenhong Zhao

  • Fenghua Zhang

  • Mario M. Leitao

  • Ran Meng

  • Yueping Liu

  • Yan Ding

  • Zhengmao Zhang

  • June 15, 2026

  • 0 min

Share

Clinical Scorecard: Surgical Interventions and Outcomes for Patients with Intestinal Metastases from Advanced Epithelial Ovarian Cancer

At a Glance

CategoryDetail
Condition
Key MechanismsMaximal cytoreductive surgery and bowel integrity preservation (source needed)
Target PopulationPatients with FIGO stage III or IV epithelial ovarian cancer (source needed)
Care Setting

Key Highlights

  • R0 resection rate of 75.4% in the cohort study (source needed)
  • Lower incidence of intraoperative complications in the bowel tumor stripping group (source needed)
  • 5-year overall survival rates similar between bowel resection and tumor stripping groups (source needed)
  • 5-year progression-free survival significantly higher in the bowel resection group (source needed)

Guideline-Based Recommendations

Diagnosis

  • Pathological confirmation of intestinal metastases required (source needed)

Management

  • Individualized surgical strategy based on intraoperative findings (source needed)

Monitoring & Follow-up

  • Postoperative follow-up for complications and survival outcomes (source needed)

Risks

  • Potential for postoperative complications such as perforation, acute peritonitis, and fistula (source needed)

Patient & Prescribing Data

255 patients with advanced epithelial ovarian cancer and intestinal metastases

Surgical options include bowel resection and tumor stripping based on tumor invasion

Clinical Best Practices

  • Preoperative bowel preparation is recommended (source needed)
  • Counsel patients regarding the possibility of bowel resection and stoma creation (source needed)
  • Aim for no macroscopic residual disease or residual lesions smaller than 1 cm (source needed)

Related Resources & Content

Original Source(s)

Related Content